Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy Subjects
Clinical trial NCT03251248 · COMPLETED
Trial details
- NCT number
- NCT03251248
- Sponsor
- Fresenius Kabi SwissBioSim GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-22
- Primary completion
- 2018-05-08
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.